Tag: Withdrawal seizures

In clinical trials, Xcopri (cenobamate) demonstrated a significant reduction in seizure frequency for many adults with focal-onset seizures. However, like many antiepileptic drugs, it comes with important safety considerations regarding seizure activity, most notably the risk of increased seizures if the medication is stopped suddenly.

In 2019, the U.S. Food and Drug Administration (FDA) issued a black box warning for zolpidem, highlighting the risk of serious injuries and fatalities from complex sleep behaviors. This action underscores the profound safety concerns surrounding this common insomnia treatment and explains why is zolpidem a high risk medication, despite its widespread use.